MORGENS WATERFALL VINTIADIS & CO INC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGENS WATERFALL VINTIADIS & CO INC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$427,000
-57.3%
50,0000.0%0.38%
-42.0%
Q3 2018$1,001,000
-44.2%
50,000
-28.1%
0.66%
-48.5%
Q2 2018$1,795,000
+103.1%
69,500
+87.8%
1.27%
+89.3%
Q1 2018$884,000
-29.5%
37,0000.0%0.67%
-31.9%
Q4 2017$1,254,00037,0000.99%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders